{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T19:17:13Z","timestamp":1772219833937,"version":"3.50.1"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Innovation Team Development Plan of Baotou Medical College","award":["byjj-efytd-006"],"award-info":[{"award-number":["byjj-efytd-006"]}]},{"name":"Public Hospital Research Joint Fund Science and Technology Project","award":["2023GLLH0208"],"award-info":[{"award-number":["2023GLLH0208"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>The aim of this study was to investigate the mechanism underlying the action of melatonin (MT) in treating cholestatic liver disease. Melatonin and therapeutic targets for cholestatic liver disease were screened. A protein\u2013protein interaction network was constructed using intersecting targets. Core targets were subjected to GO and KEGG enrichment analyses. We evaluated core target affinity through molecular docking. Biochemical indicators were measured in a mouse model of cholestasis to determine the pathological changes in liver tissue. The expression of core targets (MMP9, EGFR, and AKT) was detected through western blotting. The core targets for treating cholestatic liver disease included ALB, AKT1, ESR1, CASP3, PPARG, MMP9, PTGS2, SRC, EGFR, and IGF1. The biological processes included lipopolysaccharide stress response, bacterial molecular response, nutrient level response, and regulation of inflammatory response. Additionally, the estrogen, tumor necrosis factor-alpha, and VEGF signaling pathways were enriched in cholestatic liver disease. Molecular docking showed that MT had a strong binding affinity for MMP9, EGFR, and AKT1. Animal experiments demonstrated that melatonin alleviated inflammation and fibrosis in cholestatic liver disease, downregulated MMP9 expression, and upregulated the expression of EGFR, AKT, and phosphorylated AKT. Network pharmacology predictions suggested that these targets are closely associated with the estrogen signaling pathway. In conclusion, the protective effect of melatonin against cholestatic liver injury is likely mediated through the downregulation of MMP9 and upregulation of EGFR\/AKT.<\/jats:p>","DOI":"10.1371\/journal.pone.0342978","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T18:42:23Z","timestamp":1772217743000},"page":"e0342978","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the mechanism underlying melatonin action in cholestatic liver disease treatment via network pharmacology, molecular docking, and in vivo experiments"],"prefix":"10.1371","volume":"21","author":[{"given":"Tao","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"ZhenYu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9332-5706","authenticated-orcid":true,"given":"Wang","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"issue":"1","key":"pone.0342978.ref001","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13578-023-01035-1","article-title":"Bile acid-mediated signaling in cholestatic liver diseases","volume":"13","author":"J Zeng","year":"2023","journal-title":"Cell Biosci"},{"issue":"1","key":"pone.0342978.ref002","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s10020-024-00830-x","article-title":"The gut microbiota-bile acid axis in cholestatic liver disease","volume":"30","author":"D Sun","year":"2024","journal-title":"Mol Med"},{"issue":"1","key":"pone.0342978.ref003","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/gutjnl-2021-324305","article-title":"Novel therapeutic targets for cholestatic and fatty liver disease","volume":"71","author":"M Trauner","year":"2022","journal-title":"Gut"},{"issue":"15","key":"pone.0342978.ref004","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.3390\/cells13151296","article-title":"PPAR-Mediated Bile Acid Glucuronidation: Therapeutic Targets for the Treatment of Cholestatic Liver Diseases","volume":"13","author":"GM Gallucci","year":"2024","journal-title":"Cells"},{"issue":"1","key":"pone.0342978.ref005","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jhep.2024.09.032","article-title":"Bile acid metabolism and signalling in liver disease","volume":"82","author":"CD Fuchs","year":"2025","journal-title":"J Hepatol"},{"key":"pone.0342978.ref006","first-page":"4927403","article-title":"Melatonin Alleviates Glucose and Lipid Metabolism Disorders in Guinea Pigs Caused by Different Artificial Light Rhythms","volume":"2020","author":"W Liu","year":"2020","journal-title":"J Diabetes Res"},{"issue":"2","key":"pone.0342978.ref007","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12702","article-title":"Melatonin controversies, an update","volume":"70","author":"JA Boutin","year":"2021","journal-title":"J Pineal Res"},{"key":"pone.0342978.ref008","doi-asserted-by":"crossref","first-page":"1339304","DOI":"10.3389\/fimmu.2024.1339304","article-title":"Melatonin: the placental antioxidant and anti-inflammatory","volume":"15","author":"TT Joseph","year":"2024","journal-title":"Front Immunol"},{"issue":"3","key":"pone.0342978.ref009","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2174\/1570159X14666161228122115","article-title":"Melatonin: Pharmacology, Functions and Therapeutic Benefits","volume":"15","author":"S Tordjman","year":"2017","journal-title":"Curr Neuropharmacol"},{"key":"pone.0342978.ref010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/NSS.S290757","article-title":"Immunohistological Localization of Mel1a Melatonin Receptor in Pigeon Retina","volume":"13","author":"W Sheng","year":"2021","journal-title":"Nat Sci Sleep"},{"issue":"4","key":"pone.0342978.ref011","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/diseases8040044","article-title":"Can Melatonin Be a Potential \u201cSilver Bullet\u201d in Treating COVID-19 Patients?","volume":"8","author":"DP Cardinali","year":"2020","journal-title":"Diseases"},{"issue":"3","key":"pone.0342978.ref012","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12598","article-title":"Melatonin reduces inflammatory response in human intestinal epithelial cells stimulated by interleukin-1\u03b2","volume":"67","author":"G Mannino","year":"2019","journal-title":"J Pineal Res"},{"issue":"4","key":"pone.0342978.ref013","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3390\/ijms18040673","article-title":"Effects of Melatonin on Liver Injuries and Diseases","volume":"18","author":"J-J Zhang","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"3","key":"pone.0342978.ref014","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12639","article-title":"Melatonin and circadian rhythms in liver diseases: Functional roles and potential therapies","volume":"68","author":"K Sato","year":"2020","journal-title":"J Pineal Res"},{"issue":"4","key":"pone.0342978.ref015","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jcmgh.2022.07.007","article-title":"Prolonged Administration of Melatonin Ameliorates Liver Phenotypes in Cholestatic Murine Model","volume":"14","author":"L Ceci","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"24","key":"pone.0342978.ref016","doi-asserted-by":"crossref","first-page":"9667","DOI":"10.3390\/ijms21249667","article-title":"Melatonin Protects Cholangiocytes from Oxidative Stress-Induced Proapoptotic and Proinflammatory Stimuli via miR-132 and miR-34","volume":"21","author":"E Ostrycharz","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"4","key":"pone.0342978.ref017","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1039\/D1SC05613A","article-title":"wSDTNBI: a novel network-based inference method for virtual screening","volume":"13","author":"Z Wu","year":"2021","journal-title":"Chem Sci"},{"issue":"8","key":"pone.0342978.ref018","article-title":"Exploring Chemical Information in PubChem","volume":"1","author":"S Kim","year":"2021","journal-title":"Curr Protoc"},{"key":"pone.0342978.ref019","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"A Daina","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"pone.0342978.ref020","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkx374","article-title":"PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database","volume":"45","author":"X Wang","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"pone.0342978.ref021","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"DS Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"pone.0342978.ref022","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines","volume":"6","author":"J Ru","year":"2014","journal-title":"J Cheminform"},{"key":"pone.0342978.ref023","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baw030","article-title":"Genic insights from integrated human proteomics in GeneCards","volume":"2016","author":"S Fishilevich","year":"2016","journal-title":"Database (Oxford)"},{"key":"pone.0342978.ref024","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gky1151","article-title":"OMIM.org: leveraging knowledge across phenotype-gene relationships","volume":"47","author":"JS Amberger","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"pone.0342978.ref025","article-title":"The DisGeNET knowledge platform for disease genomics: 2019 update","volume":"48","author":"J Pi\u00f1ero","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"pone.0342978.ref026","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"D Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"pone.0342978.ref027","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"G Yu","year":"2012","journal-title":"OMICS"},{"issue":"42","key":"pone.0342978.ref028","doi-asserted-by":"crossref","first-page":"7555","DOI":"10.2174\/0929867325666180904115000","article-title":"Advances in Docking","volume":"26","author":"VB Sulimov","year":"2019","journal-title":"Curr Med Chem"},{"issue":"8","key":"pone.0342978.ref029","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings","volume":"61","author":"J Eberhardt","year":"2021","journal-title":"J Chem Inf Model"},{"issue":"2","key":"pone.0342978.ref030","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2353\/ajpath.2007.061133","article-title":"A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis","volume":"171","author":"P Fickert","year":"2007","journal-title":"Am J Pathol"},{"issue":"11","key":"pone.0342978.ref031","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1007\/s11010-023-04682-7","article-title":"Melatonin attenuates cholestatic liver injury via inhibition of the inflammatory response","volume":"478","author":"Y Tan","year":"2023","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"pone.0342978.ref032","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3390\/antiox13010043","article-title":"Melatonin Prevents Alcohol- and Metabolic Dysfunction- Associated Steatotic Liver Disease by Mitigating Gut Dysbiosis, Intestinal Barrier Dysfunction, and Endotoxemia","volume":"13","author":"KR LeFort","year":"2023","journal-title":"Antioxidants (Basel)"},{"issue":"11","key":"pone.0342978.ref033","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/pro.3715","article-title":"Toward understanding the origin and evolution of cellular organisms","volume":"28","author":"M Kanehisa","year":"2019","journal-title":"Protein Sci"},{"issue":"1","key":"pone.0342978.ref034","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"M Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"pone.0342978.ref035","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkae909","article-title":"KEGG: biological systems database as a model of the real world","volume":"53","author":"M Kanehisa","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"pone.0342978.ref036","doi-asserted-by":"crossref","first-page":"1238841","DOI":"10.3389\/fphar.2023.1238841","article-title":"Exploring the mechanism of aloe-emodin in the treatment of liver cancer through network pharmacology and cell experiments","volume":"14","author":"M Zhu","year":"2023","journal-title":"Front Pharmacol"},{"issue":"2","key":"pone.0342978.ref037","first-page":"1185","article-title":"Melatonin ameliorates ANIT\u2011induced cholestasis by activating Nrf2 through a PI3K\/Akt\u2011dependent pathway in rats","volume":"19","author":"Y Li","year":"2019","journal-title":"Mol Med Rep"},{"issue":"8","key":"pone.0342978.ref038","doi-asserted-by":"crossref","first-page":"737","DOI":"10.21037\/atm-20-5110","article-title":"The role of bile acids in cholestatic liver injury","volume":"9","author":"S-Y Cai","year":"2021","journal-title":"Ann Transl Med"},{"key":"pone.0342978.ref039","doi-asserted-by":"crossref","first-page":"111133","DOI":"10.1016\/j.fct.2020.111133","article-title":"Inflammation: Cause or consequence of chronic cholestatic liver injury","volume":"137","author":"BL Woolbright","year":"2020","journal-title":"Food Chem Toxicol"},{"issue":"4","key":"pone.0342978.ref040","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/HEP.0000000000000611","article-title":"Bile acid-induced IRF3 phosphorylation mediates cell death, inflammatory responses, and fibrosis in cholestasis-induced liver and kidney injury via regulation of ZBP1","volume":"79","author":"Y Zhuang","year":"2024","journal-title":"Hepatology"},{"issue":"1","key":"pone.0342978.ref041","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5582\/bst.2018.01247","article-title":"Anti-inflammatory, anti-oxidative stress and novel therapeutic targets for cholestatic liver injury","volume":"13","author":"Y Zhang","year":"2019","journal-title":"Biosci Trends"},{"issue":"2","key":"pone.0342978.ref042","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41575-019-0226-7","article-title":"Primary biliary cholangitis: pathogenesis and therapeutic opportunities","volume":"17","author":"AF Gulamhusein","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"24","key":"pone.0342978.ref043","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.3748\/wjg.v29.i24.3899","article-title":"Immunological factors in cirrhosis diseases from a bibliometric point of view","volume":"29","author":"D Zhang","year":"2023","journal-title":"World J Gastroenterol"},{"issue":"4","key":"pone.0342978.ref044","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/hep4.1158","article-title":"Tumor necrosis factor-\u03b1-mediated hepatocyte apoptosis stimulates fibrosis in the steatotic liver in mice","volume":"2","author":"Y Osawa","year":"2018","journal-title":"Hepatol Commun"},{"key":"pone.0342978.ref045","doi-asserted-by":"crossref","first-page":"787748","DOI":"10.3389\/fphar.2022.787748","article-title":"Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis","volume":"13","author":"F-D Wang","year":"2022","journal-title":"Front Pharmacol"},{"issue":"11","key":"pone.0342978.ref046","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1111\/j.1440-1746.2006.04629.x","article-title":"Gene expression profiling in whole liver of bile duct ligated rats: VEGF-A expression is up-regulated in hepatocytes adjacent to the portal tracts","volume":"22","author":"A Tanaka","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"pone.0342978.ref047","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ajpath.2013.11.008","article-title":"Regulation of the histamine\/VEGF axis by miR-125b during cholestatic liver injury in mice","volume":"184","author":"F Meng","year":"2014","journal-title":"Am J Pathol"},{"issue":"3","key":"pone.0342978.ref048","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jphs.2015.10.005","article-title":"Chlorogenic acid protects against cholestatic liver injury in rats","volume":"129","author":"D Wu","year":"2015","journal-title":"J Pharmacol Sci"},{"issue":"6","key":"pone.0342978.ref049","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jhep.2004.08.022","article-title":"Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis","volume":"41","author":"D Alvaro","year":"2004","journal-title":"J Hepatol"},{"issue":"1","key":"pone.0342978.ref050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/1568010043483944","article-title":"Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1\/TH2 cytokine production","volume":"3","author":"ML Salem","year":"2004","journal-title":"Curr Drug Targets Inflamm Allergy"},{"issue":"22","key":"pone.0342978.ref051","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.4103\/0366-6999.168964","article-title":"Association of Estrogen Receptor Gene Polymorphisms and Primary Biliary Cirrhosis in a Chinese Population: A Case-Control Study","volume":"128","author":"L Yang","year":"2015","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"pone.0342978.ref052","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jhep.2005.03.025","article-title":"Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial","volume":"43","author":"M Conchillo","year":"2005","journal-title":"J Hepatol"},{"issue":"6","key":"pone.0342978.ref053","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bbadis.2013.02.005","article-title":"Insulin-like growth factor 1 enhances bile-duct proliferation and fibrosis in Abcb4(-\/-) mice","volume":"1832","author":"A Sokolovi\u0107","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"pone.0342978.ref054","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/hep.27171","article-title":"Transcriptional dynamics of bile salt export pump during pregnancy: mechanisms and implications in intrahepatic cholestasis of pregnancy","volume":"60","author":"X Song","year":"2014","journal-title":"Hepatology"},{"key":"pone.0342978.ref055","doi-asserted-by":"crossref","first-page":"119367","DOI":"10.1016\/j.lfs.2021.119367","article-title":"Estrogen cholestasis induces gut and liver injury in rats involving in activating PI3K\/Akt and MAPK signaling pathways","volume":"276","author":"D Xiang","year":"2021","journal-title":"Life Sci"},{"key":"pone.0342978.ref056","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.matbio.2017.11.011","article-title":"Matrix metalloproteinase functions in hepatic injury and fibrosis","author":"M Roderfeld","year":"2018","journal-title":"Matrix Biol"},{"issue":"9","key":"pone.0342978.ref057","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.7150\/ijbs.25589","article-title":"Kupffer-derived matrix metalloproteinase-9 contributes to liver fibrosis resolution","volume":"14","author":"M Feng","year":"2018","journal-title":"Int J Biol Sci"},{"issue":"1","key":"pone.0342978.ref058","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00109-016-1462-8","article-title":"Epidermal growth factor signaling protects from cholestatic liver injury and fibrosis","volume":"95","author":"J Svinka","year":"2017","journal-title":"J Mol Med (Berl)"},{"issue":"2","key":"pone.0342978.ref059","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bbrc.2013.05.097","article-title":"Conditional loss of heparin-binding EGF-like growth factor results in enhanced liver fibrosis after bile duct ligation in mice","volume":"437","author":"T Takemura","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"pone.0342978.ref060","doi-asserted-by":"crossref","first-page":"619252","DOI":"10.3389\/fbioe.2020.619252","article-title":"Phospho-Form Specific Substrates of Protein Kinase B (AKT1)","volume":"8","author":"M McKenna","year":"2021","journal-title":"Front Bioeng Biotechnol"},{"issue":"3","key":"pone.0342978.ref061","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/clpt.2012.108","article-title":"Alanine aminotransferase: a clinical and regulatory tool for detecting liver injury-past, present, and future","volume":"92","author":"JR Senior","year":"2012","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"pone.0342978.ref062","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1002\/hep.27715","article-title":"Liver alkaline phosphatase: a missing link between choleresis and biliary inflammation","volume":"61","author":"R Poupon","year":"2015","journal-title":"Hepatology"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0342978","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T18:42:39Z","timestamp":1772217759000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0342978"}},"subtitle":[],"editor":[{"given":"Zhiling","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":62,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0342978","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]}}}